Soreide Law Group has been contacted by clients who purchased Asterias Biotherapeutics, Inc. (AST) and experienced stock losses.  Not only were the brokers from Laidlaw and Company offering this stock, but Laidlaw also served as the underwriter of the offering. Securities that are newly issued are typically more volatile than the older more established companies, […]

Soreide Law Group has received calls from clients who purchased Cytori Therapeutics, Inc. (CYTX) and have suffered significant stock losses.  This security was offered by brokers at Laidlaw and Company, who were also the underwriter of the offering. Newly issued securities are typically more volatile than older more established companies, and if as an investor […]